23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Anusha Sivaramakrishnan

Executive Director, Head - Enterprise Project Management and Governance

Arvinas

New York, United States

18 profile visitsSpeakerSpeaker

My organisation

Arvinas

Arvinas

Manufacturer

New York, United States

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma. Based in the biotech hub of New Haven, CT, Arvinas is driven by an industry-leading team dedicated to improving the lives of people living with serious diseases. For more information, visit www.arvinas.com.
Read more

About me

My organisation

Arvinas

Social media

Speaker sessions (3)

Wednesday, 16 October 2024

11:00 - 11:30

PANEL DISCUSSION: Organizational processes behind decision making

Location:Beacon Hill Ballroom
  • Deciding On The Right Mix Of Therapeutic Areas

Thursday, 17 October 2024

15:30 - 16:00